Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis
2021 · Molecular Therapy — Oncolytics · 43 citations
https://doi.org/10.1016/j.omto.2021.06.012
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
673
Citations
13
h-index
13
i10-index
Xuebo Chen is an academic researcher from University of Science and Technology Liaoning. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA Research and Splicing & Adenosine and Purinergic Signaling. The author has an h-index of 13, co-authored 20 publications.
ORCID: 0000-0002-0069-8555https://doi.org/10.1016/j.omto.2021.06.012
https://doi.org/10.1186/s40170-022-00293-w
Click to start Chat